Related Experiment Video
Updated: May 21, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Ifosfamide induced Fanconi syndrome
Samantha Buttemer1, Mohan Pai, Keith K Lau
1Health Sciences Department, McMaster University, Hamilton, Canada.
Ifosfamide chemotherapy can cause Fanconi syndrome and rickets in children with Wilms' tumour. Careful monitoring is crucial for managing these potential toxicities during treatment.
Area of Science:
- Pediatric Oncology
- Nephrology
- Clinical Pharmacology
Background:
- Ifosfamide (IFA) is a vital chemotherapeutic agent for pediatric cancers.
- Renal toxicities, including hemorrhagic cystitis and Fanconi syndrome, limit IFA's clinical application.
Observation:
- A case study details a child with Wilms' tumor who developed rickets and Fanconi syndrome during IFA treatment.
- This highlights the risk of iatrogenic complications associated with IFA chemotherapy.
Findings:
- Ifosfamide-induced Fanconi syndrome can manifest as rickets in pediatric patients.
- Close patient monitoring is essential to detect and manage IFA-related renal toxicities.
Implications:
- Understanding the pathomechanism of IFA-induced Fanconi syndrome is advancing.
- Future strategies may enable selective renal protection during Ifosfamide chemotherapy.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications